๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Enhancing the Technology of Clinical Trials and the Trials Model to Evaluate Newly Developed, Targeted Antidepressants

โœ Scribed by Martin M Katz; Uriel M Halbreich; Charles L Bowden; Alan Frazer; Roger M Pinder; A.John Rush; David P Wheatley; Barry D Lebowitz


Book ID
114281030
Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
86 KB
Volume
27
Category
Article
ISSN
1470-634X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Enhancing endocrine response with novel
โœ Stephen R. D. Johnston; Alexandra Leary; Lesley-Ann Martin; Ian E. Smith; Mitch ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 114 KB

Acquired resistance to endocrine therapies has severely limited their long-term effectiveness in breast cancer. In recent years a clear rationale has developed for combining signal transduction inhibitors (STIs) with endocrine therapies to delay the emergence of acquired resistance and enhance endoc

Clinical trials of potential antidepress
โœ Maria Stella T. Giron; Johan Fastbom; Bengt Winblad ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 132 KB

## Abstract ## Background There is widespread use of antidepressants in the elderly population. The principle of treatment of depression, however, is derived mostly from studies employing young adults and healthy elderly. This article reviews the literature on the extent to which the elderly are r